Zhejiang Zuoli Pharmaceutical

Zhejiang Zuoli Pharmaceutical is a leading Chinese pharmaceutical company focused on the modernization of Traditional Chinese Medicine (TCM) through advanced biotechnology. The company is renowned for its proprietary medicinal fungi fermentation technology, which is used to produce its flagship Wuling series, including the Wuling Capsule for treating insomnia, anxiety, and depression. In addition to its psychiatric and neurological portfolio, Zuoli Pharmaceutical develops and markets treatments for urological conditions and hematological disorders like iron deficiency anemia. Publicly traded on the Shenzhen Stock Exchange, the company maintains a vertically integrated structure encompassing research, large-scale fermentation manufacturing, and a nationwide distribution network in China.